✦ LIBER ✦

Paclitaxel plus cisplatin favoured in ovarian cancer

Book ID: 121642465
Publisher: Adis International Limited (now part of Wolters Kluwer Health)
Year: 1999
Weight: 129 KB
Volume: 197
Category: Article
ISSN: 1173-5503
DOI: 10.1007/BF03274814

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Paclitaxel plus cisplatin increases surv

Paclitaxel plus cisplatin increases survival, costs in ovarian cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 139 KB

Paclitaxel plus cisplatin increases surv

Paclitaxel plus cisplatin increases survival, costs in ovarian cancer

📂 Article 📅 2002 🏛 Adis International Limited (now part of Wolters Kl ⚖ 136 KB

Update on paclitaxel plus cisplatin in a

Update on paclitaxel plus cisplatin in advanced ovarian cancer

✍ Schäffer, J.; Floege, J.; Koch, K. M. 📂 Article 📅 1998 🏛 Adis International Limited (now part of Wolters Kl ⚖ 166 KB

Paclitaxel plus cisplatin and lonidamine

Paclitaxel plus cisplatin and lonidamine showed `good activity' in advanced ovarian cancer,

📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 133 KB

Cisplatin plus paclitaxel superior in ce

Cisplatin plus paclitaxel superior in cervical cancer?

✍ Bankhead, Charles 📂 Article 📅 2001 🏛 Adis International Limited (now part of Wolters Kl ⚖ 146 KB

Intraperitoneal Cisplatin and Paclitaxel

Intraperitoneal Cisplatin and Paclitaxel in Ovarian Cancer

✍ Armstrong, Deborah K.; Bundy, Brian; Wenzel, Lari; Huang, Helen Q.; Baergen, Reb 📂 Article 📅 2006 🏛 Massachusetts Medical Society 🌐 English ⚖ 751 KB